Christopher Blunden
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 4
- Co-authors
- Paul Lephart (4 shared papers)Jason M. Pogue (4 shared papers)Keith S. Kaye (4 shared papers)Dror Marchaim (4 shared papers)Suchitha Bheemreddy (4 shared papers)Kayoko Hayakawa (4 shared papers)Teena Chopra (4 shared papers)Robert A. Bonomo (3 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (2 papers)The Journal of Pediatrics (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)American Journal of Infection Control (1 paper)American Journal of Medical Quality (1 paper)
- Partner nations
- United StatesNigeriaIsrael
In The Last Decade
Christopher Blunden
7 papers receiving 299 citations
Peers
Comparison fields: 5 of 39
- Molecular Medicine 208
- Applied Microbiology and Biotechnology 62
- Clinical Biochemistry 47
- Endocrinology 36
- Pharmacology 61
Countries citing papers authored by Christopher Blunden
This map shows the geographic impact of Christopher Blunden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Blunden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Blunden more than expected).
Fields of papers citing papers by Christopher Blunden
This network shows the impact of papers produced by Christopher Blunden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Blunden. The network helps show where Christopher Blunden may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Blunden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 109 | |
| 2 | 2012 | 65 | |
| 3 | 2011 | 59 | |
| 4 | 2012 | 47 | |
| 5 | 2021 | 11 | |
| 6 | 2018 | 9 | |
| 7 | 2020 | 2 | |
| 8 | 2015 | 0 |
About Christopher Blunden
Christopher Blunden is a scholar working on Molecular Medicine, Pulmonary and Respiratory Medicine, Molecular Biology, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 302 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Neonatal Health and Biochemistry (1 paper), Atherosclerosis and Cardiovascular Diseases (1 paper), Antibiotic Use and Resistance (1 paper), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (1 paper), Thyroid Disorders and Treatments (1 paper), Cardiovascular Disease and Adiposity (1 paper) and Sexual Differentiation and Disorders (1 paper). The work is most often cited by research in Molecular Medicine (208 citations), Applied Microbiology and Biotechnology (62 citations), Clinical Biochemistry (47 citations), Endocrinology (36 citations) and Pharmacology (61 citations). Christopher Blunden has collaborated with scholars based in United States, Nigeria and Israel. Frequent co-authors include Paul Lephart, Jason M. Pogue, Keith S. Kaye, Dror Marchaim, Suchitha Bheemreddy, Kayoko Hayakawa, Teena Chopra, Robert A. Bonomo, Sorabh Dhar and Federico Pérez. Their work appears in journals such as Infection Control and Hospital Epidemiology, The Journal of Pediatrics, Antimicrobial Agents and Chemotherapy, American Journal of Infection Control and American Journal of Medical Quality.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.